Analyst Larry Biegelsen of Wells Fargo maintained a Buy rating on Intuitive Surgical, boosting the price target to $599.00.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Larry Biegelsen has given his Buy rating due to a combination of factors, including Intuitive Surgical’s strong financial performance in the second quarter. The company reported revenues of $2.44 billion, marking a significant year-over-year increase of 21.4%, and earnings per share of $2.19, both surpassing market expectations.
Additionally, the company’s procedure growth guidance for 2025 was raised, indicating robust future prospects. The launch of the DV5 system in the U.S., along with strategic expansions in Europe and Japan, further supports the positive outlook. Moreover, the reduction in expected tariff impacts and the increase in gross margin guidance reflect improved operational efficiencies, contributing to the Buy rating.
In another report released today, Barclays also maintained a Buy rating on the stock with a $635.00 price target.